RGENRepligen Corporation Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Medical - Instruments & Supplies

Current Price: $117.78 (+0.00% today)

Market Cap: $6.63B

P/E (TTM): 136.20

Forward P/E (FY1): 59.20

EPS Growth: 26.9%

Analyst Upside: 69.8%

Relative Strength (RS%): 1

-33.0% from 52-week high

Back to Scanner

RGEN

NASDAQRS 1Score 30

Repligen Corporation

HealthcareMedical - Instruments & Supplies$6.63B3 setups passing
$117.78
0.0% ($0.00)
-33.0% from 52W High
P/E (TTM)
136.20
Fwd P/E
59.20
PEG
0.45
Analyst Upside
+69.8%
EPS Growth
26.9%
Gross Margin
50.9%
ROE
2.4%
D/E
0.33
Div Yield
0.0%
Avg Volume
797.3K

Price Chart

Key Levels

SMA 200
$138.31
SMA 50
$132.94
Price
$117.78
52W High
$175.79
Target
$200.00

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst